ITOS
Price
$10.55
Change
+$0.64 (+6.46%)
Updated
Feb 23, 2:53 PM EST
26 days until earnings call
LABP
Price
$6.01
Change
+$0.23 (+3.98%)
Updated
Feb 23, 2:54 PM EST
Ad is loading...

Compare trend and price ITOS vs LABP

Header iconITOS vs LABP Comparison
Open Charts ITOS vs LABPBanner chart's image
iTeos Therapeutics
Price$10.55
Change+$0.64 (+6.46%)
Volume$400
CapitalizationN/A
Landos Biopharma
Price$6.01
Change+$0.23 (+3.98%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
ITOS vs LABP Comparison Chart

Loading...

ITOSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ITOS vs. LABP commentary
Feb 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITOS is a StrongSell and LABP is a Hold.

COMPARISON
Comparison
Feb 23, 2024
Stock price -- (ITOS: $9.92 vs. LABP: $5.78)
Brand notoriety: ITOS and LABP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITOS: 105% vs. LABP: 169%
Market capitalization -- ITOS: $354.99M vs. LABP: $18.01M
ITOS [@Biotechnology] is valued at $354.99M. LABP’s [@Biotechnology] market capitalization is $18.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $538.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITOS’s FA Score shows that 1 FA rating(s) are green whileLABP’s FA Score has 1 green FA rating(s).

  • ITOS’s FA Score: 1 green, 4 red.
  • LABP’s FA Score: 1 green, 4 red.
According to our system of comparison, LABP is a better buy in the long-term than ITOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITOS’s TA Score shows that 3 TA indicator(s) are bullish.

  • ITOS’s TA Score: 3 bullish, 6 bearish.

Price Growth

ITOS (@Biotechnology) experienced а -1.49% price change this week, while LABP (@Biotechnology) price change was +5.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.34%. For the same industry, the average monthly price growth was +19.68%, and the average quarterly price growth was +40.54%.

Reported Earning Dates

ITOS is expected to report earnings on May 09, 2024.

LABP is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (+3.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ITOS with price predictions.
OPEN
A.I.dvisor published
a Summary for LABP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ITOS($355M) has a higher market cap than LABP($18M). LABP YTD gains are higher at: 57.923 vs. ITOS (-9.406). LABP has higher annual earnings (EBITDA): -22.63M vs. ITOS (-87.99M). ITOS has more cash in the bank: 599M vs. LABP (42.5M). LABP has less debt than ITOS: LABP (27K) vs ITOS (5.93M). ITOS has higher revenues than LABP: ITOS (66.5M) vs LABP (0).
ITOSLABPITOS / LABP
Capitalization355M18M1,972%
EBITDA-87.99M-22.63M389%
Gain YTD-9.40657.923-16%
P/E Ratio41.49N/A-
Revenue66.5M0-
Total Cash599M42.5M1,409%
Total Debt5.93M27K21,959%
TECHNICAL ANALYSIS
Technical Analysis
ITOS
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 8 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ITOSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGERX14.450.30
+2.12%
Federated Hermes Global Equity R6
FSCPX60.961.20
+2.01%
Fidelity Select Consumer Discret Port
TICRX23.340.44
+1.92%
TIAA-CREF Social Choice Eq Retail
MECEX13.900.23
+1.68%
MainStay Epoch Capital Growth C
ACEVX8.280.06
+0.73%
American Century International Val Inv

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been closely correlated with RCUS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if ITOS jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
-5.97%
RCUS - ITOS
68%
Closely correlated
+19.87%
VSTM - ITOS
51%
Loosely correlated
-2.43%
BEAM - ITOS
47%
Loosely correlated
+5.60%
NTLA - ITOS
43%
Loosely correlated
+1.12%
XNCR - ITOS
43%
Loosely correlated
+1.20%
More

LABP and

Correlation & Price change

A.I.dvisor indicates that over the last year, LABP has been loosely correlated with MDGL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LABP jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LABP
1D Price
Change %
LABP100%
N/A
MDGL - LABP
39%
Loosely correlated
+8.89%
SNPX - LABP
33%
Loosely correlated
-28.51%
ELEV - LABP
33%
Poorly correlated
-2.53%
NRIX - LABP
32%
Poorly correlated
+4.98%
SLNO - LABP
30%
Poorly correlated
-0.25%
More